In the comparison of clinical baseline data between c-Met low expression and high expression groups (age, sex, tumor size, tumor location, TNM stage, clinicopathological stage, degree of differentiation, positive expression of HER2, and H. pylori), there was an apparent difference in the M stage and clinicopathological stage (p < 0.05) (Table 2). Here, ERBB2 is linked to neoplasm.